ストックスクリーナーアプリを入手
16.03
1.60%
-0.26
前日終値:
$16.29
開ける：
$16.32
24時間の取引高:
363.21K
Relative Volume:
0.71
時価総額：
$462.38M
収益：
$322.67M
当期純損益:
$-61.63M
株価収益率:
-8.1561
EPS:
-1.9654
ネットキャッシュフロー:
$-124.21M
1週間 パフォーマンス:
-0.62%
1か月 パフォーマンス:
-1.84%
6か月 パフォーマンス:
-32.13%
1年 パフォーマンス:
-15.19%
1日の値動き範囲:
$15.81
$16.48
1週間の範囲:
$15.81
$16.52
52週間の値動き範囲:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
16.03 | 462.38M | 322.67M | -61.63M | -124.21M | -1.9654 |
TMO
Thermo Fisher Scientific Inc
|
466.70 | 173.44B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.57 | 126.39B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.93 | 44.55B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.42 | 32.34B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
311.20 | 30.55B | 3.17B | 642.63M | 516.49M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-05 | アップグレード | UBS | Neutral → Buy |
| 2023-12-07 | 開始されました | UBS | Neutral |
| 2022-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 開始されました | Raymond James | Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-02-04 | 再開されました | Piper Sandler | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Underperform |
| 2021-01-08 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-08-20 | 開始されました | Oppenheimer | Outperform |
| 2020-05-29 | 開始されました | BTIG Research | Buy |
| 2019-11-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
すべてを表示
Fulgent Genetics Inc (FLGT) 最新ニュース
Fulgent Genetics (FLGT) to Release Earnings on Friday - MarketBeat
Fulgent Genetics rises on earnings, revenue beat - MSN
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting - BioSpace
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Analysts - MarketBeat
Fulgent Genetics to present nano-encapsulated anti-tumor drug FID-007 efficacy at ASCO meeting - Traders Union
Head and neck cancer study from Fulgent gets ASCO oral slot - Stock Titan
Fulgent Genetics (FLGT) Stock Pre Market (Momentum Building) 2026-04-18Top Picks - Cổng thông tin điện tử Tỉnh Sơn La
Fulgent Genetics Under Investigation for Securities Law Violations - Intellectia AI
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - lincolnjournal.com
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 - BioSpace
Press Release: Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 - Moomoo
Stock Recap: Whats the analyst consensus on Fulgent Genetics Inc2026 Growth vs Value & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Pullback Watch: Is Fulgent Genetics Inc a momentum stock2026 Levels & Daily Momentum Trading Reports - baoquankhu1.vn
Stop Loss: Can Fulgent Genetics Inc stock outperform in a bear market2026 Biggest Moves & Risk Managed Investment Entry Signals - baoquankhu1.vn
Fulgent Genetics Inc (FLGT) Stock Down 3.9% -- Now Undervalued? GF Score: 64/100 - GuruFocus
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Buyback Watch: What is the long term forecast for Fulgent Genetics Inc stockEarnings Trend Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Fulgent Genetics Inc stock outperform in a bear marketTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Surprises Report: Can Fulgent Genetics Inc stock outperform in a bear market2026 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
Should I Buy Fulgent Genetics (FLGT) Stock in 2026 | Price at $16.69, Down 0.77%Wall Street Picks - Cổng thông tin điện tử Tỉnh Sơn La
Hennion & Walsh Asset Management Inc. Makes New $1.74 Million Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, ... - Bluefield Daily Telegraph
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Dow Update: What are Fulgent Genetics Incs technical support levelsWeekly Stock Analysis & Risk Managed Investment Signals - baoquankhu1.vn
Aug Volume: What is the long term forecast for Fulgent Genetics Inc stockWeekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
FLGT PE Ratio & Valuation, Is FLGT Overvalued - Intellectia AI
JPMorgan Chase & Co. Increases Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc - ACCESS Newswire
Fulgent Genetics (NASDAQ: FLGT) CEO cancels 750,000-share prepaid forward - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CEO reports 30.7% ownership stake - Stock Titan
[ARS] Fulgent Genetics, Inc. SEC Filing - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) outlines 2026 meeting, pay and equity plan votes - Stock Titan
Fulgent Genetics (FLGT) price target decreased by 27.72% to 24.82 - MSN
Short Interest in Fulgent Genetics Rises 38.7% - National Today
Technical Reactions to FLGT Trends in Macro Strategies - Stock Traders Daily
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Rises By 38.7% - MarketBeat
Fulgent Genetics Receives 'Hold' Rating from Analysts - National Today
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc. - lincolnjournal.com
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent ... - Bluefield Daily Telegraph
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
If You Invested $1,000 in Fulgent Genetics (FLGT) - Stock Titan
Aug Weekly: How is Fulgent Genetics Inc managing supply chain issues2026 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - The Chronicle-Journal
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Fulgent Genetics Completes $56.9M Acquisition of Bako Diagnostics and StrataDx to Expand Precision Medicine Services - Minichart
Trading the Move, Not the Narrative: (FLGT) Edition - Stock Traders Daily
Published on: 2026-03-19 03:58:12 - baoquankhu1.vn
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics completes $56.9M pathology lab acquisitions By Investing.com - Investing.com Australia
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Fulgent Genetics Inc (FLGT) 財務データ
収益
当期純利益
現金流量
EPS
2.82%
大文字化:
|
ボリューム (24 時間):